Paid Clinical Trials Detroit
Discover 1,186 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Location:
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15
Sponsor:
Moderna
Location:
Code:
NCT05575492
Conditions
Cytomegalovirus
Eligibility Criteria
Sex: All
Age: 9 - 15
Healthy Volunteers: Accepted
Interventions
mRNA-1647
Placebo
RRMMMMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM
Sponsor:
Multiple Myeloma Research Consortium
Location:
Code:
NCT06171685
Conditions
Relapse Multiple Myeloma
Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Teclistamab Monotherapy
Teclistamab
Selinexor & ChemotherapySelinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
Sponsor:
Barbara Ann Karmanos Cancer Institute
Location:
Code:
NCT03147885
Conditions
Diffuse Large B-Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma
Recurrent Extranodal Marginal Zone Lymphoma
Recurrent Follicular Lymphoma
Recurrent Indolent Adult Non-Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Selinexor
Observational StudySustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays
Sponsor:
Henry Ford Health System
Location:
Code:
NCT04562285
Conditions
Covid19
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Serologic immunoassays to SARS-CoV-2 antibodies
BR-AMNon-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM
Sponsor:
BioStem Technologies
Location:
Code:
NCT06565156
Conditions
Non-infected Diabetic Foot Ulcer
Diabetic Foot
Diabetic Wound
Diabetic Foot Ulcer
Non-ischemic Diabetic Foot Ulcer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BR-AM
Standard Care
NXC-201 CAR-TStudy of NXC-201 CAR-T in Patients with Light Chain (AL) Amyloidosis
Sponsor:
Nexcella Inc.
Location:
Code:
NCT06097832
Conditions
Light Chain (AL) Amyloidosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
NXC-201 CAR-T
CARE-CPCARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
Sponsor:
Wake Forest University Health Sciences
Location:
Code:
NCT05897632
Conditions
Chest Pain
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Outpatient Evaluation
Hospitalization Evaluation
Tinengotinib vs. Physician's ChoiceStudy of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
Sponsor:
TransThera Sciences (Nanjing), Inc.
Location:
Code:
NCT05948475
Conditions
Cholangiocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tinengotinib 8 mg
Tinengotinib 10 mg
Physician's Choice
autoRICRemote Ischemic Conditioning Using the autoRIC
Sponsor:
CellAegis US, Inc.
Location:
Code:
NCT03318575
Conditions
Ischemia-Reperfusion Injury
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
autoRIC
autoRIC Sham
DersimelagonExtension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Sponsor:
Mitsubishi Tanabe Pharma America Inc.
Location:
Code:
NCT05005975
Conditions
EPP
XLP
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
MT-7117